|
| 37743037 | Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER). | Clin Gastroenterol Hepatol | 2024 |
| 37864829 | Analysis of Clinical Trial Screen Failures in Inflammatory Bowel Diseases [IBD]: Real World Results from the International Organization for the study of IBD. | J Crohns Colitis | 2024 |
| 36377259 | Crohn's disease shared decision making intervention leads to more patients choosing combination therapy: a cluster randomised controlled trial. | Aliment Pharmacol Ther | 2023 |
| 35341952 | An Office-Based, Point-of-Care Test Predicts Treatment Outcomes With Community-Based Pelvic Floor Physical Therapy in Patients With Chronic Constipation. | Clin Gastroenterol Hepatol | 2023 |
| 35640124 | Bidirectional Correlations Between Health Confidence and Inflammatory Bowel Disease Activity: A Nationwide Longitudinal Cohort Study. | Inflamm Bowel Dis | 2023 |
| 37086490 | Validation of a rapid HLA-DQA1*05 pharmacogenomics assay to identify at-risk resistance to anti-tumor necrosis factor therapy among patients with inflammatory bowel disease. | Am J Clin Pathol | 2023 |
| 37225135 | A Comparative Evaluation of the Measurement Properties of Three Histological Indices of Mucosal Healing in Ulcerative Colitis: Geboes Score, Robarts Histopathology Index and Nancy Index. | J Crohns Colitis | 2023 |
| 36436154 | An Expert Consensus to Standardize Assessment of Bowel Cleansing for Clinical Trials of Bowel Preparations for Crohn's Disease. | Dig Dis Sci | 2023 |
| 36937140 | The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease. | Crohns Colitis 360 | 2023 |
| 36840812 | Patients with IBD Want to Talk About Sleep and Treatments for Insomnia with Their Gastroenterologist. | Dig Dis Sci | 2023 |
| 36179129 | Concordance and Discordance Between Patient-reported Remission, Patient-reported Outcomes, and Physician Global Assessment. | Inflamm Bowel Dis | 2023 |
| 36266592 | Existing Bowel Preparation Quality Scales Are Reliable in the Setting of Centralized Endoscopy Reading. | Dig Dis Sci | 2023 |
| 36130188 | Patients with Inflammatory Bowel Disease Have Heterogeneous Treatment Preferences That Are Largely Determined by the Avoidance of Abdominal Pain and Side Effects [P-POWER IBD Study]. | J Crohns Colitis | 2023 |
| 36191274 | The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium. | Am J Gastroenterol | 2023 |
| 33039584 | Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis. | Clin Gastroenterol Hepatol | 2022 |
| 35771656 | Hyperbaric Oxygen as Successful Monotherapy for a Severe Ulcerative Colitis Flare. | Inflamm Bowel Dis | 2022 |
| 35378331 | The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients. | Cell Mol Gastroenterol Hepatol | 2022 |
| 35640865 | Collaborative Co-Managed Care (C<sup>3</sup>): A Sustainable Gastrointestinal Motility Practice Model. | Clin Gastroenterol Hepatol | 2022 |
| 35365535 | Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn's disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial). | BMJ Open | 2022 |
| 35788348 | CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. | Gastroenterology | 2022 |
| 35633043 | The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course. | Aliment Pharmacol Ther | 2022 |
| 35416799 | Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel. | Am J Gastroenterol | 2022 |
| 35413359 | Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery. | Gastroenterology | 2022 |
| 36777421 | Inflammatory Bowel Disease and Pain Interference: A Conceptual Model for the Role of Insomnia, Fatigue, and Pain Catastrophizing. | Crohns Colitis 360 | 2022 |
| 36777042 | Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection. | Crohns Colitis 360 | 2022 |
| 36465489 | The Use of Telemedicine in Older Patients with Gastrointestinal Diseases. | Curr Treat Options Gastroenterol | 2022 |
| 36865590 | Multidisciplinary Inflammatory Bowel Disease Care to Manage Medication Nonadherence and History of Anorexia Nervosa: A Case Report. | Gastroenterol Hepatol (N Y) | 2022 |
| 36208633 | Partially randomised, patient preference trials for inflammatory bowel disease. | Lancet Gastroenterol Hepatol | 2022 |
| 35964690 | A Summary of the BRIDGe Summit on Damage-Related Progression of Ulcerative Colitis: Establishing Research Priorities. | Gastroenterology | 2022 |
| 36300960 | Treat-to-Target: The Era of Targeted Immunosuppressive Agents in IBD Management. | R I Med J (2013) | 2022 |
| 33549864 | Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease. | Clin Gastroenterol Hepatol | 2022 |
| 35189386 | IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus. | Clin Gastroenterol Hepatol | 2022 |
| 35006492 | Appropriateness of Medical and Surgical Treatments for Chronic Pouchitis Using RAND/UCLA Appropriateness Methodology. | Dig Dis Sci | 2022 |
| 35170531 | Somatosensory assessments in patients with inflammatory bowel disease: a cross-sectional study examining pain processing pathways and the role of multiple patient factors. | Eur J Gastroenterol Hepatol | 2022 |
| 34893849 | Health Confidence Is Associated With Disease Outcomes and Health Care Utilization in Inflammatory Bowel Disease: A Nationwide Cross-sectional Study. | Inflamm Bowel Dis | 2022 |
| 34350943 | Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease. | J Crohns Colitis | 2022 |
| 34037211 | Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process. | Inflamm Bowel Dis | 2022 |
| 34115661 | Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD. | J Clin Gastroenterol | 2022 |
| 34331174 | Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders. | Dig Dis Sci | 2022 |
| 32300936 | Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review. | Dig Dis Sci | 2021 |
| 36777269 | Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's Disease. | Crohns Colitis 360 | 2021 |
| 33629956 | Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study. | J Med Internet Res | 2021 |
| 34849970 | Point-of-care dashboards promote coproduction of healthcare services for patients with inflammatory bowel disease. | Int J Qual Health Care | 2021 |
| 34969664 | A pilot feasibility trial of cognitive-behavioural therapy for insomnia in people with inflammatory bowel disease. | BMJ Open Gastroenterol | 2021 |
| 34391771 | Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease. | Gastroenterology | 2021 |
| 34388143 | A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease. | Am J Gastroenterol | 2021 |
| 34388141 | Evaluating the Impact of Cost on the Treatment Algorithm for Chronic Idiopathic Constipation: Cost-Effectiveness Analysis. | Am J Gastroenterol | 2021 |
| 34797226 | Quality of Care Program Reduces Unplanned Health Care Utilization in Patients With Inflammatory Bowel Disease. | Am J Gastroenterol | 2021 |
| 31887442 | Perspectives From Patients and Gastroenterologists on De-escalating Therapy for Crohn's Disease. | Clin Gastroenterol Hepatol | 2021 |
| 33252119 | Immunogenicity of Tumor Necrosis Factor Antagonists and Effect of Dose Escalation on Anti-Drug Antibodies and Serum Drug Concentrations in Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2021 |